Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Oyama

Showing results (161-170 of 198) with videos related to

Pageof 20
Sort By:
Cancer Chemotherapy Reports|June 1, 1972
Combination therapy with mitomycin C (NSC-26980), 5-fluorouracil (NSC-19893), and cytosine arabinoside (NSC-63878) for advanced cancer in manK Ota, S Kurita, M Nishimura, et al.
Journal of Veterinary Internal Medicine|June 30, 2019
Plasma and tissue angiotensin-converting enzyme 2 activity and plasma equilibrium concentrations of angiotensin peptides in dogs with heart diseaseÉva Larouche-Lebel, Kerry A Loughran, Mark A Oyama, et al.
Journal of Veterinary Internal Medicine|April 12, 2019
ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogsBruce W Keene, Clarke E Atkins, John D Bonagura, et al.
Research in Veterinary Science|April 7, 2015
Alpha-smooth muscle actin and serotonin receptors 2A and 2B in dogs with myxomatous mitral valve diseaseS E Cremer, S G Moesgaard, C E Rasmussen, et al.
Journal of Veterinary Internal Medicine|July 1, 2023
Effect of a specially formulated diet on progression of heart enlargement in dogs with subclinical degenerative mitral valve diseaseMark A Oyama, Brian A Scansen, Adrian Boswood, et al.
Journal of Veterinary Internal Medicine|March 9, 2026
Effect of the sodium glucose transporter-2 inhibitor dapagliflozin on urine and blood biomarkers in dogs with heart diseaseLaura K Massey, Jessica L Ward, Alexandra V Crooks, et al.
Journal of Veterinary Internal Medicine|December 1, 2023
Urine sodium concentration after intravenous furosemide in dogs with acute congestive heart failure and correlation with treatment efficacyVictoria Convey, Terry Huh, Erin J Achilles, et al.
Journal of Molecular and Cellular Cardiology|January 2, 2018
Serotonin receptor 2B signaling with interstitial cell activation and leaflet remodeling in degenerative mitral regurgitationKathryn H Driesbaugh, Emanuela Branchetti, Juan B Grau, et al.
Journal of Veterinary Internal Medicine|March 27, 2024
Utility of focused cardiac ultrasonography training in veterinary students to differentiate stages of subclinical myxomatous mitral valve disease in dogsTerry Huh, Erin J Achilles, Laura K Massey, et al.
Journal of Veterinary Internal Medicine|June 22, 2011
Comparison of polymerase chain reaction with bacterial 16s primers to blood culture to identify bacteremia in dogs with suspected bacterial endocarditisK M Meurs, A M Heaney, C E Atkins, et al.
Pageof 20

Showing results (161-170 of 198) with videos related to

Sort By:
Pageof 20
Cancer Chemotherapy Reports|June 1, 1972
Combination therapy with mitomycin C (NSC-26980), 5-fluorouracil (NSC-19893), and cytosine arabinoside (NSC-63878) for advanced cancer in manK Ota, S Kurita, M Nishimura, et al.
Journal of Veterinary Internal Medicine|June 30, 2019
Plasma and tissue angiotensin-converting enzyme 2 activity and plasma equilibrium concentrations of angiotensin peptides in dogs with heart diseaseÉva Larouche-Lebel, Kerry A Loughran, Mark A Oyama, et al.
Journal of Veterinary Internal Medicine|April 12, 2019
ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogsBruce W Keene, Clarke E Atkins, John D Bonagura, et al.
Research in Veterinary Science|April 7, 2015
Alpha-smooth muscle actin and serotonin receptors 2A and 2B in dogs with myxomatous mitral valve diseaseS E Cremer, S G Moesgaard, C E Rasmussen, et al.
Journal of Veterinary Internal Medicine|July 1, 2023
Effect of a specially formulated diet on progression of heart enlargement in dogs with subclinical degenerative mitral valve diseaseMark A Oyama, Brian A Scansen, Adrian Boswood, et al.
Journal of Veterinary Internal Medicine|March 9, 2026
Effect of the sodium glucose transporter-2 inhibitor dapagliflozin on urine and blood biomarkers in dogs with heart diseaseLaura K Massey, Jessica L Ward, Alexandra V Crooks, et al.
Journal of Veterinary Internal Medicine|December 1, 2023
Urine sodium concentration after intravenous furosemide in dogs with acute congestive heart failure and correlation with treatment efficacyVictoria Convey, Terry Huh, Erin J Achilles, et al.
Journal of Molecular and Cellular Cardiology|January 2, 2018
Serotonin receptor 2B signaling with interstitial cell activation and leaflet remodeling in degenerative mitral regurgitationKathryn H Driesbaugh, Emanuela Branchetti, Juan B Grau, et al.
Journal of Veterinary Internal Medicine|March 27, 2024
Utility of focused cardiac ultrasonography training in veterinary students to differentiate stages of subclinical myxomatous mitral valve disease in dogsTerry Huh, Erin J Achilles, Laura K Massey, et al.
Journal of Veterinary Internal Medicine|June 22, 2011
Comparison of polymerase chain reaction with bacterial 16s primers to blood culture to identify bacteremia in dogs with suspected bacterial endocarditisK M Meurs, A M Heaney, C E Atkins, et al.
Pageof 20